Literature DB >> 24508412

Positron emission tomography with computed tomography-based diagnosis of massive extramedullary progression in a patient with high-risk multiple myeloma.

Elena Zamagni1, Cristina Nanni2, Paola Tacchetti3, Lucia Pantani3, Giulia Marzocchi3, Beatrice Zannetti3, Carolina Terragna3, Katia Mancuso3, Serena Rocchi3, Annalisa Pezzi3, Nicoletta Testoni3, Stefano Fanti2, Michele Cavo3.   

Abstract

Entities:  

Keywords:  Extramedullary disease; Multiple myeloma; Novel agents; PET/CT; Prognosis

Mesh：

Substances：

Year:  2013        PMID： 24508412     DOI： 10.1016/j.clml.2013.12.014

Source DB:  PubMed          Journal:  Clin Lymphoma Myeloma Leuk        ISSN： 2152-2669


× No keyword cloud information.
  5 in total

1.  Image interpretation criteria for FDG PET/CT in multiple myeloma: a new proposal from an Italian expert panel. IMPeTUs (Italian Myeloma criteria for PET USe).

Authors:  Cristina Nanni; Elena Zamagni; Annibale Versari; Stephane Chauvie; Andrea Bianchi; Marco Rensi; Marilena Bellò; Ilaria Rambaldi; Andrea Gallamini; Francesca Patriarca; Francesca Gay; Barbara Gamberi; Michele Cavo; Stefano Fanti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-10-16       Impact factor: 9.236

Review 2.  Therapy assessment in multiple myeloma with PET.

Authors:  Cristina Nanni; Elena Zamagni
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-06-01       Impact factor: 9.236

3.  Bone marrow tracer uptake pattern of PET-CT in multiple myeloma: image interpretation and prognostic value.

Authors:  Jing Li; Hui Tan; Tianhong Xu; Hongcheng Shi; Peng Liu
Journal:  Ann Hematol       Date:  2021-08-20       Impact factor: 3.673

Review 4.  Central Nervous System Myeloma and Unusual Extramedullary Localizations: Real Life Practical Guidance.

Authors:  Vincenzo Sammartano; Alfonso Cerase; Valentina Venanzi; Maria Antonietta Mazzei; Beatrice Esposito Vangone; Francesco Gentili; Ivano Chiarotti; Monica Bocchia; Alessandro Gozzetti
Journal:  Front Oncol       Date:  2022-07-07       Impact factor: 5.738

5.  Circulating Serum MicroRNA-130a as a Novel Putative Marker of Extramedullary Myeloma.

Authors:  Lenka Besse; Lenka Sedlarikova; Fedor Kryukov; Jana Nekvindova; Lenka Radova; Ondrej Slaby; Petr Kuglik; Martina Almasi; Miroslav Penka; Marta Krejci; Zdenek Adam; Ludek Pour; Sabina Sevcikova; Roman Hajek
Journal:  PLoS One       Date:  2015-09-21       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.